RECOVER-Treating Long COVID (RECOVER-TLC)invites patients, caregivers, advocates, healthcare providers, & researchers to provide feedback on the draft protocol synopsis for its upcoming glucagon-like peptide-1 receptor agonist (GLP-1 RA) clinical trial.
https://recovercovid.org/news/recover-tlc-announces-public-comment-period-upcoming-clinical-trial

RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.






